Santhera Pharmaceuticals Holding AG (SWX: SANN)
Switzerland
· Delayed Price · Currency is CHF 9.18
-0.11 (-1.18%)
Sep 4, 2024, 1:00 PM CET
SANN Income Statement
Financials in millions CHF. Fiscal year is July - June.
Millions CHF. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | 81.11 | 81.4 | 94.02 | 109.26 | 103.66 | 101.91 | Upgrade
|
| Revenue Growth (YoY) | -11.34% | -13.43% | -13.95% | 5.41% | 1.71% | 16.95% | Upgrade
|
| Cost of Revenue | 67.54 | 70.46 | 92.24 | 96.76 | 94.83 | 88.12 | Upgrade
|
| Gross Profit | 13.57 | 10.93 | 1.78 | 12.51 | 8.83 | 13.8 | Upgrade
|
| Selling, General & Admin | 3.48 | 3.45 | 4.04 | 4.7 | 5.82 | 5.07 | Upgrade
|
| Other Operating Expenses | -0.91 | -1.41 | 6.99 | 4.55 | 7.59 | 6.86 | Upgrade
|
| Operating Expenses | 9.11 | 8.5 | 17.68 | 16.04 | 20.83 | 19.71 | Upgrade
|
| Operating Income | 4.45 | 2.44 | -15.91 | -3.53 | -12 | -5.92 | Upgrade
|
| Interest Expense | -1.05 | -0.85 | -0.77 | -0.7 | -0.61 | -0.44 | Upgrade
|
| Interest & Investment Income | 0.69 | 0 | 0 | 0.52 | 0.01 | 0.02 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -0.27 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | 1.16 | -0.06 | 0 | -0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.15 | -0.15 | -0.45 | -0.03 | -0.27 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | 3.91 | 1.41 | -15.96 | -3.79 | -12.86 | -6.76 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.62 | -0.62 | - | - | - | - | Upgrade
|
| Pretax Income | -2.28 | 0.8 | -15.96 | -3.79 | -12.86 | -6.76 | Upgrade
|
| Income Tax Expense | 0.89 | 0.77 | 0.95 | 0.04 | -0.42 | -0.44 | Upgrade
|
| Earnings From Continuing Operations | -3.17 | 0.03 | -16.9 | -3.83 | -12.45 | -6.32 | Upgrade
|
| Minority Interest in Earnings | -0.01 | -0.01 | -0.04 | -0.23 | 0.32 | -0.07 | Upgrade
|
| Net Income | -3.18 | 0.02 | -16.95 | -4.05 | -12.13 | -6.4 | Upgrade
|
| Net Income to Common | -3.18 | 0.02 | -16.95 | -4.05 | -12.13 | -6.4 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 0.42% | 0.10% | 0.08% | 0.35% | 0.68% | 11.76% | Upgrade
|
| EPS (Basic) | -2.27 | 0.02 | -12.18 | -2.92 | -8.75 | -4.65 | Upgrade
|
| EPS (Diluted) | -2.27 | 0.02 | -12.18 | -2.92 | -8.75 | -4.65 | Upgrade
|
| Free Cash Flow | -2.66 | -5.78 | -14.46 | -2.26 | 7.28 | -2 | Upgrade
|
| Free Cash Flow Per Share | -1.91 | -4.15 | -10.39 | -1.62 | 5.25 | -1.45 | Upgrade
|
| Gross Margin | 16.73% | 13.43% | 1.89% | 11.45% | 8.52% | 13.54% | Upgrade
|
| Operating Margin | 5.49% | 2.99% | -16.92% | -3.23% | -11.57% | -5.80% | Upgrade
|
| Profit Margin | -3.92% | 0.03% | -18.02% | -3.71% | -11.70% | -6.28% | Upgrade
|
| Free Cash Flow Margin | -3.28% | -7.10% | -15.38% | -2.07% | 7.02% | -1.96% | Upgrade
|
| EBITDA | 10.14 | 8.04 | -9.86 | 2.79 | -5.22 | 1.12 | Upgrade
|
| EBITDA Margin | 12.50% | 9.88% | -10.49% | 2.55% | -5.04% | 1.10% | Upgrade
|
| D&A For EBITDA | 5.69 | 5.61 | 6.04 | 6.32 | 6.77 | 7.03 | Upgrade
|
| EBIT | 4.45 | 2.44 | -15.91 | -3.53 | -12 | -5.92 | Upgrade
|
| EBIT Margin | 5.49% | 2.99% | -16.92% | -3.23% | -11.57% | -5.80% | Upgrade
|
| Effective Tax Rate | - | 96.35% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.